Financhill
Sell
45

PSGTF Quote, Financials, Valuation and Earnings

Last price:
$0.15
Seasonality move :
1.05%
Day range:
$0.15 - $0.15
52-week range:
$0.12 - $0.39
Dividend yield:
3.98%
P/E ratio:
54.55x
P/S ratio:
0.45x
P/B ratio:
0.38x
Volume:
--
Avg. volume:
667
1-year change:
-62.18%
Market cap:
$995.9M
Revenue:
$2.3B
EPS (TTM):
$0.00

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, PT Semen Indonesia (Persero) Tbk has -- downside to fair value with a price target of -- per share.

PSGTF vs. S&P 500

  • Over the past 5 trading days, PT Semen Indonesia (Persero) Tbk has overperformed the S&P 500 by 0.31% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • PT Semen Indonesia (Persero) Tbk does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • PT Semen Indonesia (Persero) Tbk revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter PT Semen Indonesia (Persero) Tbk reported revenues of $465.9M.

Earnings Growth

  • PT Semen Indonesia (Persero) Tbk earnings have been falling on a year-over-year basis for 10 quarters in a row. In the most recent quarter PT Semen Indonesia (Persero) Tbk reported earnings per share of $0.00.
Enterprise value:
1.6B
EV / Invested capital:
--
Price / LTM sales:
0.45x
EV / EBIT:
15.05x
EV / Revenue:
0.74x
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
11.05x
Gross Profit (TTM):
$454.6M
Return On Assets:
0.38%
Net Income Margin (TTM):
0.83%
Return On Equity:
0.61%
Return On Invested Capital:
0.49%
Operating Margin:
3.33%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $2.4B $2.5B $2.2B $534.3M $465.9M
Gross Profit $707.2M $646.9M $454.6M $140.8M $95M
Operating Income $304M $276.3M $93.9M $56.4M $15.5M
EBITDA $354.1M $333.9M $148.6M $72.2M $28.4M
Diluted EPS $0.03 $0.02 $0.00 $0.00 $0.00
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $1.1B $1.1B $1.2B $1.2B $977.6M
Total Assets $5.3B $5.4B $5.4B $5.1B $4.6B
Current Liabilities $888.5M $1B $729.8M $929.9M $754.6M
Total Liabilities $3B $2.6B $2.2B $2.1B $1.7B
Total Equity $2.4B $2.8B $3.2B $3B $2.9B
Total Debt $1.6B $1.2B $1B $942.9M $601.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations -$6.3M -- -- -- --
Cash From Investing -$33.3M -$112.2M -$84.3M -$17.3M -$6.2M
Cash From Financing -$190.9M -$175.8M -$382.5M -$9.1M -$12.2M
Free Cash Flow -- -- -- -- --
PSGTF
Sector
Market Cap
$995.9M
$19.1M
Price % of 52-Week High
37.82%
69%
Dividend Yield
3.98%
0%
Shareholder Yield
--
0.76%
1-Year Price Total Return
-62.18%
-6.25%
Beta (5-Year)
0.462
0.746
Dividend yield:
3.98%
Annualized payout:
$0.01
Payout ratio:
197.36%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $0.15
200-day SMA
Sell
Level $0.19
Bollinger Bands (100)
Buy
Level 0.11 - 0.17
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $0.15
Relative Strength Index (RSI14)
Buy
Level 94.41
ADX Line
Neutral
Level
Williams %R
Buy
Level -100
50-day SMA
Buy
Level $0.13
MACD (12, 26)
Buy
Level 0.02
25-day Aroon Oscillator
Sell
Level 0
On Balance Volume
Neutral
Level --

Financial Scores

Hold
Altman Z-Score (Annual)
Level (1.8105)
Buy
CA Score (Annual)
Level (0.0708)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (1)
Buy
Ohlson Score
Level (0.2758)
--
Piotroski F Score (Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

PT Semen Indonesia (Persero) Tbk manufactures and sells cement and other building materials to the construction and building industries. The firm is organized into two segments by product: cement and non-cement. The cement segment, which generates the vast majority of revenue, produces and sells cement. The non-cement segment produces and sells limestone, clay quarrying, ready-mix concrete, and industry cluster development, which converts post-mining sites into areas that can be used for public facilities, reforestation, and commercial development. The vast majority of revenue comes from Indonesia.

Stock Forecast FAQ

In the current month, PSGTF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PSGTF average analyst price target in the past 3 months is --.

  • Where Will PT Semen Indonesia (Persero) Tbk Stock Be In 1 Year?

    According to analysts, the consensus estimate is that PT Semen Indonesia (Persero) Tbk share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About PT Semen Indonesia (Persero) Tbk?

    Analysts are divided on their view about PT Semen Indonesia (Persero) Tbk share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PT Semen Indonesia (Persero) Tbk is a Sell and believe this share price will rise from its current level to --.

  • What Is PT Semen Indonesia (Persero) Tbk's Price Target?

    The price target for PT Semen Indonesia (Persero) Tbk over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PSGTF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for PT Semen Indonesia (Persero) Tbk is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of PSGTF?

    You can purchase shares of PT Semen Indonesia (Persero) Tbk via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PT Semen Indonesia (Persero) Tbk shares.

  • What Is The PT Semen Indonesia (Persero) Tbk Share Price Today?

    PT Semen Indonesia (Persero) Tbk was last trading at $0.15 per share. This represents the most recent stock quote for PT Semen Indonesia (Persero) Tbk. Yesterday, PT Semen Indonesia (Persero) Tbk closed at $0.15 per share.

  • How To Buy PT Semen Indonesia (Persero) Tbk Stock Online?

    In order to purchase PT Semen Indonesia (Persero) Tbk stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock